Plasma Fractionation Market Size, Share & Trends

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Plasma Fractionation Market Size Analysis

Global Plasma Fractionation Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Albumin
  1. By Value
3. Immunoglobulins
  1. By Value
  2. Intravenous immunoglobulins
    1. Intravenous immunoglobulins By Value
  3. Subcutaneous immunoglobulins
    1. Subcutaneous immunoglobulins By Value
  4. Others
    1. Others By Value
4. Coagulation Factors
  1. By Value
  2. Factor VIII
    1. Factor VIII By Value
  3. Factor IX
    1. Factor IX By Value
  4. Von Willebrand Factor
    1. Von Willebrand Factor By Value
  5. Prothrombin Complex Concentrates
    1. Prothrombin Complex Concentrates By Value
  6. Fibrinogen Concentrates
    1. Fibrinogen Concentrates By Value
  7. Others
    1. Others By Value
5. Protease Inhibitors
  1. By Value
6. Others
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Centrifugation
  1. By Value
3. Depth Filtration
  1. By Value
4. Chromatography
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Neurology
  1. By Value
3. Hematology
  1. By Value
4. Oncology
  1. By Value
5. Immunology
  1. By Value
6. Pulmonology
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Research
  1. By Value
4. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Albumin
  1. By Value
3. Immunoglobulins
  1. By Value
  2. Intravenous immunoglobulins
    1. Intravenous immunoglobulins By Value
  3. Subcutaneous immunoglobulins
    1. Subcutaneous immunoglobulins By Value
  4. Others
    1. Others By Value
4. Coagulation Factors
  1. By Value
  2. Factor VIII
    1. Factor VIII By Value
  3. Factor IX
    1. Factor IX By Value
  4. Von Willebrand Factor
    1. Von Willebrand Factor By Value
  5. Prothrombin Complex Concentrates
    1. Prothrombin Complex Concentrates By Value
  6. Fibrinogen Concentrates
    1. Fibrinogen Concentrates By Value
  7. Others
    1. Others By Value
5. Protease Inhibitors
  1. By Value
6. Others
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Centrifugation
  1. By Value
3. Depth Filtration
  1. By Value
4. Chromatography
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Neurology
  1. By Value
3. Hematology
  1. By Value
4. Oncology
  1. By Value
5. Immunology
  1. By Value
6. Pulmonology
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Research
  1. By Value
4. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Albumin
    1. By Value
  3. Immunoglobulins
    1. By Value
    2. Intravenous immunoglobulins
      1. Intravenous immunoglobulins By Value
    3. Subcutaneous immunoglobulins
      1. Subcutaneous immunoglobulins By Value
    4. Others
      1. Others By Value
  4. Coagulation Factors
    1. By Value
    2. Factor VIII
      1. Factor VIII By Value
    3. Factor IX
      1. Factor IX By Value
    4. Von Willebrand Factor
      1. Von Willebrand Factor By Value
    5. Prothrombin Complex Concentrates
      1. Prothrombin Complex Concentrates By Value
    6. Fibrinogen Concentrates
      1. Fibrinogen Concentrates By Value
    7. Others
      1. Others By Value
  5. Protease Inhibitors
    1. By Value
  6. Others
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Centrifugation
    1. By Value
  3. Depth Filtration
    1. By Value
  4. Chromatography
    1. By Value
  5. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Neurology
    1. By Value
  3. Hematology
    1. By Value
  4. Oncology
    1. By Value
  5. Immunology
    1. By Value
  6. Pulmonology
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Research
    1. By Value
  4. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Albumin
  1. By Value
3. Immunoglobulins
  1. By Value
  2. Intravenous immunoglobulins
    1. Intravenous immunoglobulins By Value
  3. Subcutaneous immunoglobulins
    1. Subcutaneous immunoglobulins By Value
  4. Others
    1. Others By Value
4. Coagulation Factors
  1. By Value
  2. Factor VIII
    1. Factor VIII By Value
  3. Factor IX
    1. Factor IX By Value
  4. Von Willebrand Factor
    1. Von Willebrand Factor By Value
  5. Prothrombin Complex Concentrates
    1. Prothrombin Complex Concentrates By Value
  6. Fibrinogen Concentrates
    1. Fibrinogen Concentrates By Value
  7. Others
    1. Others By Value
5. Protease Inhibitors
  1. By Value
6. Others
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Centrifugation
  1. By Value
3. Depth Filtration
  1. By Value
4. Chromatography
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Neurology
  1. By Value
3. Hematology
  1. By Value
4. Oncology
  1. By Value
5. Immunology
  1. By Value
6. Pulmonology
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Research
  1. By Value
4. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Albumin
    1. By Value
  3. Immunoglobulins
    1. By Value
    2. Intravenous immunoglobulins
      1. Intravenous immunoglobulins By Value
    3. Subcutaneous immunoglobulins
      1. Subcutaneous immunoglobulins By Value
    4. Others
      1. Others By Value
  4. Coagulation Factors
    1. By Value
    2. Factor VIII
      1. Factor VIII By Value
    3. Factor IX
      1. Factor IX By Value
    4. Von Willebrand Factor
      1. Von Willebrand Factor By Value
    5. Prothrombin Complex Concentrates
      1. Prothrombin Complex Concentrates By Value
    6. Fibrinogen Concentrates
      1. Fibrinogen Concentrates By Value
    7. Others
      1. Others By Value
  5. Protease Inhibitors
    1. By Value
  6. Others
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Centrifugation
    1. By Value
  3. Depth Filtration
    1. By Value
  4. Chromatography
    1. By Value
  5. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Neurology
    1. By Value
  3. Hematology
    1. By Value
  4. Oncology
    1. By Value
  5. Immunology
    1. By Value
  6. Pulmonology
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Research
    1. By Value
  4. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Albumin
  1. By Value
3. Immunoglobulins
  1. By Value
  2. Intravenous immunoglobulins
    1. Intravenous immunoglobulins By Value
  3. Subcutaneous immunoglobulins
    1. Subcutaneous immunoglobulins By Value
  4. Others
    1. Others By Value
4. Coagulation Factors
  1. By Value
  2. Factor VIII
    1. Factor VIII By Value
  3. Factor IX
    1. Factor IX By Value
  4. Von Willebrand Factor
    1. Von Willebrand Factor By Value
  5. Prothrombin Complex Concentrates
    1. Prothrombin Complex Concentrates By Value
  6. Fibrinogen Concentrates
    1. Fibrinogen Concentrates By Value
  7. Others
    1. Others By Value
5. Protease Inhibitors
  1. By Value
6. Others
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Centrifugation
  1. By Value
3. Depth Filtration
  1. By Value
4. Chromatography
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Neurology
  1. By Value
3. Hematology
  1. By Value
4. Oncology
  1. By Value
5. Immunology
  1. By Value
6. Pulmonology
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Research
  1. By Value
4. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Albumin
    1. By Value
  3. Immunoglobulins
    1. By Value
    2. Intravenous immunoglobulins
      1. Intravenous immunoglobulins By Value
    3. Subcutaneous immunoglobulins
      1. Subcutaneous immunoglobulins By Value
    4. Others
      1. Others By Value
  4. Coagulation Factors
    1. By Value
    2. Factor VIII
      1. Factor VIII By Value
    3. Factor IX
      1. Factor IX By Value
    4. Von Willebrand Factor
      1. Von Willebrand Factor By Value
    5. Prothrombin Complex Concentrates
      1. Prothrombin Complex Concentrates By Value
    6. Fibrinogen Concentrates
      1. Fibrinogen Concentrates By Value
    7. Others
      1. Others By Value
  5. Protease Inhibitors
    1. By Value
  6. Others
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Centrifugation
    1. By Value
  3. Depth Filtration
    1. By Value
  4. Chromatography
    1. By Value
  5. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Neurology
    1. By Value
  3. Hematology
    1. By Value
  4. Oncology
    1. By Value
  5. Immunology
    1. By Value
  6. Pulmonology
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Research
    1. By Value
  4. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Albumin
  1. By Value
3. Immunoglobulins
  1. By Value
  2. Intravenous immunoglobulins
    1. Intravenous immunoglobulins By Value
  3. Subcutaneous immunoglobulins
    1. Subcutaneous immunoglobulins By Value
  4. Others
    1. Others By Value
4. Coagulation Factors
  1. By Value
  2. Factor VIII
    1. Factor VIII By Value
  3. Factor IX
    1. Factor IX By Value
  4. Von Willebrand Factor
    1. Von Willebrand Factor By Value
  5. Prothrombin Complex Concentrates
    1. Prothrombin Complex Concentrates By Value
  6. Fibrinogen Concentrates
    1. Fibrinogen Concentrates By Value
  7. Others
    1. Others By Value
5. Protease Inhibitors
  1. By Value
6. Others
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Centrifugation
  1. By Value
3. Depth Filtration
  1. By Value
4. Chromatography
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Neurology
  1. By Value
3. Hematology
  1. By Value
4. Oncology
  1. By Value
5. Immunology
  1. By Value
6. Pulmonology
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Research
  1. By Value
4. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Albumin
    1. By Value
  3. Immunoglobulins
    1. By Value
    2. Intravenous immunoglobulins
      1. Intravenous immunoglobulins By Value
    3. Subcutaneous immunoglobulins
      1. Subcutaneous immunoglobulins By Value
    4. Others
      1. Others By Value
  4. Coagulation Factors
    1. By Value
    2. Factor VIII
      1. Factor VIII By Value
    3. Factor IX
      1. Factor IX By Value
    4. Von Willebrand Factor
      1. Von Willebrand Factor By Value
    5. Prothrombin Complex Concentrates
      1. Prothrombin Complex Concentrates By Value
    6. Fibrinogen Concentrates
      1. Fibrinogen Concentrates By Value
    7. Others
      1. Others By Value
  5. Protease Inhibitors
    1. By Value
  6. Others
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Centrifugation
    1. By Value
  3. Depth Filtration
    1. By Value
  4. Chromatography
    1. By Value
  5. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Neurology
    1. By Value
  3. Hematology
    1. By Value
  4. Oncology
    1. By Value
  5. Immunology
    1. By Value
  6. Pulmonology
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Research
    1. By Value
  4. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Albumin
  1. By Value
3. Immunoglobulins
  1. By Value
  2. Intravenous immunoglobulins
    1. Intravenous immunoglobulins By Value
  3. Subcutaneous immunoglobulins
    1. Subcutaneous immunoglobulins By Value
  4. Others
    1. Others By Value
4. Coagulation Factors
  1. By Value
  2. Factor VIII
    1. Factor VIII By Value
  3. Factor IX
    1. Factor IX By Value
  4. Von Willebrand Factor
    1. Von Willebrand Factor By Value
  5. Prothrombin Complex Concentrates
    1. Prothrombin Complex Concentrates By Value
  6. Fibrinogen Concentrates
    1. Fibrinogen Concentrates By Value
  7. Others
    1. Others By Value
5. Protease Inhibitors
  1. By Value
6. Others
  1. By Value
By Method
1. Introduction
  1. Method By Value
2. Centrifugation
  1. By Value
3. Depth Filtration
  1. By Value
4. Chromatography
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Neurology
  1. By Value
3. Hematology
  1. By Value
4. Oncology
  1. By Value
5. Immunology
  1. By Value
6. Pulmonology
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals & Clinics
  1. By Value
3. Clinical Research
  1. By Value
4. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Albumin
    1. By Value
  3. Immunoglobulins
    1. By Value
    2. Intravenous immunoglobulins
      1. Intravenous immunoglobulins By Value
    3. Subcutaneous immunoglobulins
      1. Subcutaneous immunoglobulins By Value
    4. Others
      1. Others By Value
  4. Coagulation Factors
    1. By Value
    2. Factor VIII
      1. Factor VIII By Value
    3. Factor IX
      1. Factor IX By Value
    4. Von Willebrand Factor
      1. Von Willebrand Factor By Value
    5. Prothrombin Complex Concentrates
      1. Prothrombin Complex Concentrates By Value
    6. Fibrinogen Concentrates
      1. Fibrinogen Concentrates By Value
    7. Others
      1. Others By Value
  5. Protease Inhibitors
    1. By Value
  6. Others
    1. By Value
2. By Method
  1. Introduction
    1. Method By Value
  2. Centrifugation
    1. By Value
  3. Depth Filtration
    1. By Value
  4. Chromatography
    1. By Value
  5. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Neurology
    1. By Value
  3. Hematology
    1. By Value
  4. Oncology
    1. By Value
  5. Immunology
    1. By Value
  6. Pulmonology
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals & Clinics
    1. By Value
  3. Clinical Research
    1. By Value
  4. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Plasma Fractionation Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Grifols S.A.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
CSL Limited
Takeda Pharmaceutical Company Limited
Octapharma AG
Kedrion S.p.A
LFB S.A.
Biotest AG
Sanquin
Bio Products Laboratory Ltd.
Intas Pharmaceuticals Ltd.
Grifols, S.A.
ADMA Biologics
China Biologic Products Holdings Inc.
GC Pharma
Hualan Bioengineering Co., Ltd.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment